Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00176969 · ClinicalTrials.gov registry record · Phase 4
Response of Topical Capsaicin in Alopecia Areata
A Phase 4 study, sponsored by University of Minnesota.
- Completed
- Registry status
- Phase 4
- Development phase
- 24
- Enrollment target
NCT00176969 is a Phase 4 study that has completed, run by University of Minnesota. The registered enrollment target is 24 participants.
The verdict
NCT00176969, a Phase 4 study, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 24 participants
- Enrollment target
Study Summary
It has been postulated that Alopecia Areata (AA) is, at least in part, a neurologically mediated disease. Research supporting this theory includes the finding that nerves surrounding the hair follicles are collapsed. We want to take this research a step further and show that not only are these perifollicular nerves collapsed, but that their function is also impaired.
Interventions
- DRUG Capsaicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 1997-08 |
| Est. Completion | 2000-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00176969
The ClinicalTrials.gov registry entry for NCT00176969 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Capsaicin is the first listed.
NCT00176969 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00176969 about?
NCT00176969 is a clinical study titled "Response of Topical Capsaicin in Alopecia Areata". It has been postulated that Alopecia Areata (AA) is, at least in part, a neurologically mediated disease. Research supporting this theory includes the finding that nerves surrounding the hair follicles are collapsed. We want to take this research a step further and show that not only are these perif...
What is the current status of trial NCT00176969?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 24 participants. The study started on 1997-08. Estimated completion is 2000-06.
What interventions are being tested in trial NCT00176969?
The interventions under investigation include: Capsaicin (DRUG).
Who is sponsoring clinical trial NCT00176969?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.